Digital therapeutics (DTx) are revolutionizing healthcare — from smart inhalers to virtual therapy avatars. As more patients turn to DTx apps, companies rush to deliver innovative features. But in the race to innovate, many developers neglect vital elements of success, leading to major setbacks, especially when seeking FDA approval. It’s time to find a practical path forward to mitigate risk and scale smarter.
The Digital Therapeutics Trifecta:
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine Prevention
What You Should Know:
- Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization for CT-132, the first prescription digital therapeutic specifically indicated for the preventive treatment of episodic migraine in adults aged 18 and older.
- The FDA granted a De Novo Classification Request for
Read More
ATA Action Acquires Digital Therapeutics Alliance, Forms New Digital Health Coalition
What You Should Know:
- ATA Action, the advocacy arm of the American Telemedicine Association (ATA), has announced its acquisition of the Digital Therapeutics Alliance (DTA), the leading international organization focused on expanding access to digital therapeutics (DTx).
- The acquisition creates a powerful, unified platform for policy and advocacy, dedicated to advancing innovative technologies that are reshaping patient care. The Boards of Directors of the ATA, ATA Action,
Read More
Dassault Systèmes Invests in Click Therapeutics to Advance Digital Therapeutics
What You Should Know:
- Dassault Systèmes has announced a strategic investment in Click Therapeutics, a pioneering company in prescription digital therapeutics (PDTs) and software-enhanced (SE) drug therapies. This investment signifies Dassault Systèmes' commitment to transforming the patient experience within the life sciences and healthcare sectors through comprehensive, end-to-end technology solutions.
The investment builds upon the existing collaboration between Dassault
Read More
Mika Health, AstraZeneca, and Daiichi Sankyo Partner on UNITE Program
What You Should Know:
- Mika Health, a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called "UNITE" alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo.
- The strategic initiative signifies a commitment to cross-industry collaboration to enhance the lives of cancer patients and is expected to pave the way for AI-powered solutions in other disease areas.
Mika Health: A Proven Digital Therapeutic Platform
Mika
Read More
Virtual Therapeutics Acquires Akili: Stock to Go Private After Merger
What You Should Know:
- Virtual Therapeutics, a leader in using engaging games for mental health treatment, announced today it will acquire Akili, Inc. (Nasdaq: AKLI), a prominent digital therapeutics company. This merger creates a diversified powerhouse in the digital health industry.
- Once the acquisition is complete, Akili's common stock will be delisted from all public stock exchanges. The combined entity's focus on mental health and broader digital therapeutics solutions
Read More
UNP Scores $32M for AI-Powered Macrocycle Therapeutics
What You Should Know:
- Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding.
- Led by Merck Global Health Innovation Fund (MGHIF) and TechBio-focused ARTIS Ventures, the funding will help propel UNP's innovative platform and expand its reach beyond oncology, tackling a wider range of medical challenges.
Macrocycles: Nature's Key to Untapped Drug
Read More
U.S. Digital Therapeutics Market to Reach $21.46B by 2030
What You Should Know:
The U.S. digital therapeutics market size is estimated to reach $21.46B by 2030, expanding at a CAGR of 33.8% from 2023 to 2030, according to a new reports by Coherent Market Insights, Inc. Digital therapeutics solutions help improve medication adherence with personalized incentives to encourage long-term behavior change in patients and people with chronic conditions. The report reveals government initiatives to digitalize healthcare is one of the key trends
Read More
Improving Physical Therapist and Patient Experiences with Technology Innovation
Today’s physical therapists are exhausted and drowning in debt from school loans. Looking at the physical therapy (PT) profession as a whole, there is an average turnover rate of 13.6%, a significant portion of the current healthcare industry’s staggering rate of 100.5% turnover, over the last 5 years, according to Daily Pay’s Healthcare Turnover Rates [2022 Edition]. What’s even more concerning is that 1 in 3 rehab professionals describe themselves as burnt-out.
What’s contributing to such
Read More
Expectations For The Connected Care Business In The Years Ahead
Though we seldom see their use in our modern world and, even then, only in fiction, there was a time when it was common for people to actually use things like crystal balls and divining rods to try to uncover unknown yet valuable information. As unbelievable as it may seem, soothsayers peered into crystal balls aiming to help seekers look into the future for guidance, while prospectors would rely earnestly on divining rods as they attempted to locate underground riches of water or oil.
While
Read More
